article thumbnail

Sanofi launches €3 million Planet Mobilization fund to support employees’ environmental projects

The Pharma Data

To date, the company has already notably: reduced GHG emission from its activities by 27% since 2015; designed a new entirely recyclable cardboard packaging for vaccines, which replaces aluminum and PVC blisters; reused, recycled, or recovered 73% of its waste; and reduced by 22% its water withdrawal from 2015 to 2020.

article thumbnail

eMDR System Enhancements

FDA Law Blog: Biosimilars

Since the final rule took effect on August 14, 2015, medical device manufacturers and importers have been required to submit MDRs in an electronic format. For any major changes, additional time will be granted between the release of the implementation package and production deployment.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Sandoz Application for proposed biosimilar adalimumab’s high concentration formulation accepted by EMA

The Pharma Data

As part of the comprehensive submission package to the EMA, Sandoz conducted a Phase I pharmacokinetics (PK) bridging study comparing Hyrimoz 50 mg/mL 2 and Hyrimoz HCF. 2,3 In 2015, the EMA and US FDA approved Humira ® HCF, which contains adalimumab at a concentration of 100 mg/mL.

article thumbnail

Ensuring reliable assays: Why the ideal microplate is an invisible one

Drug Discovery World

Then Nexus was acquired by Brooks Automation and we were able to acquire the Aurora business in October 2015. Everything is packaged in antistatic bags to dissipate any static that might become relevant. So Aurora Discovery was formed, which operated until 2009 when we merged the business with Nexus Biosystems.

article thumbnail

Q&A: The IND Journey Phase I – Navigating Success

Advarra

Q: What is the typical time period between the submission of the briefing package and the pre-IND meeting? A: The FDA’s guidance document indicates the briefing package is submitted four weeks before the meeting. Q: The speaker just stated that the Meeting Package is due 60 days before the meeting date. of this guidance.

article thumbnail

Sandoz receives approval by European Commission for Hyrimoz® (adalimumab) high-concentration formulation

The Pharma Data

As part of the comprehensive submission package to the European Marketing Authorization, Sandoz conducted a Phase I pharmacokinetics (PK) bridging study comparing its approved adalimumab 50 mg/mL 2 with the 100 mg/mL (HCF). 1 In 2015, the EMA and US FDA approved Humira ® HCF, which contains adalimumab at a concentration of 100 mg/mL.

article thumbnail

Commercial interests contribute to drug use and addiction

National Institute on Drug Abuse: Nora's Blog

Cannabis products are often sold in colorful packages that mimic kid-friendly snack foods, for example, making them appealing to children and to young people. Trends in Cannabis Use Among Older Adults in the United States, 2015-2018. Adolescents exposed to cannabis marketing have greater odds of using the drug. 2020; 66(2):247-254.

Drugs 105